Illinois Administrative Code › Title 68 - PROFESSIONS AND OCCUPATIONS › Part 1320 - OPTOMETRIC PRACTICE ACT OF 1987 › Subpart C - DIAGNOSTIC AND THERAPEUTIC OCULAR PHARMACEUTICAL AGENTS › Section 1320.335 - Oral Pharmaceutical Agents

Current through Register Vol. 48, No. 28, July 12, 2024
a) Any optometrist licensed before January 1,
				2008, prior to utilizing or prescribing any oral pharmaceutical agents
				permitted under the Act (except non-narcotic oral analgesic and over the
				counter agents), shall successfully complete a course of study and testing as
				designated in Section
				1320.335(b).
				Graduates from an approved program of optometry subsequent to January 1, 2008
				shall not be required to complete the course and may utilize and prescribe all
				oral pharmaceutical agents permitted by the Act.
b) An approved course of study in oral
				pharmaceutical agents shall be approved by the Board and shall meet the
				following requirements:
1) The program has a
				faculty that comprises a sufficient number of instructors to make certain that
				the educational obligations to the students are fulfilled. The faculty must
				have demonstrated competence in their area of teaching as evidenced by
				appropriate degrees from accredited colleges or institutions and clinical and
				teaching experience.
2) The program
				has a curriculum that contains updates in at least the following areas:
A) Patient medical history/drug
				history.
B) General
				pharmacokinetics or oral administration.
C) Concerns in special populations.
D) Treatment of ocular disease with oral
				pharmaceutical agents, including contraindications, drug interactions, systemic
				toxicities and ocular effects for the following:
i) Oral anti-infective agents
* Oral anti-bacterial
* Oral anti-fungals
* Oral anti-virals
ii) Oral anti-glaucoma agents
* CAIs
* Osmotic agents
iii) Oral anti-allergy agents
* Antihistamines
* Mast-cell degranulation inhibitors
* Decongestant combinations
iv) Oral anti-inflammatory agents
* Steroids
* NSAIDS
v) Oral analgesics
* NSAIDS
* Opiates
E) Clinical case studies, including the use
				of controlled substances, treatment options, patient management and referral in
				the following areas:
i) Infectious ocular
				disease
* Bacterial
* Viral
* Fungal
ii) Glaucoma
iii) Allergic eye disease
iv) Inflammatory ocular disease
v) Management of ocular pain
vi) Treatment of drug induced
				emergencies
F)
				Jurisprudence
Illinois Optometric Practice Act Rules - pharmaceutical
				  agents
i) Requirements
ii) Restrictions
3) The program includes a minimum
				of 12 instructional hours with an examination designed to test the student's
				knowledge and ability to apply the program's subject matter.
A) The examination shall be administered and
				proctored by a licensed CE sponsor. All examinations must be developed and
				approved by a program of optometry approved under Section
				1320.20.
B) Verification of student identification
				shall be required.
C) The content
				of all examinations shall be made available to the Division for review upon
				request.
4) In addition
				to all other requirements, the program must meet the requirements of Section
				1320.80 (Continuing Education).
				12 hours of continuing education credit will be granted for successful
				completion of the course and test in the renewal period in which the lecture
				portion of the course was completed.
5) Requests for course approval must be
				submitted to the Division no later than 90 days prior to the beginning of the
				course. Sponsors shall provide course documentation and any other documentation
				required by the Board.